Most conversations about secondary transfer restrictions focus on ROFR — the right of first refusal that lets a company or its designated shareholders match an outside buyer's offer. ROFR is well understood, time-boxed, and ultimately workable: if the company doesn't exercise it, the transfer proceeds. But a significant number of equity plans and stockholder agreements contain a separate, more powerful provision: the company's right to approve or deny any transfer at its sole and absolute discretion, regardless of whether it wants to exercise ROFR. This provision does not receive nearly enough attention from sellers planning a secondary transaction.

ROFR and consent are not the same thing

ROFR is a right to match. If the company or its preferred shareholders don't match the proposed price, the transfer proceeds to the outside buyer. Consent is a right to block. Some agreements give the board the power to reject a proposed transfer without having to purchase the shares themselves and without having to justify the decision to the seller. The seller is simply told that consent was not granted.

In practice, many equity plan documents layer both provisions. A transfer agreement might require the seller to: (1) notify the company and trigger the ROFR process, and (2) separately obtain written board or administrator consent before any transfer can close. Both conditions must be satisfied. A seller who focuses only on ROFR waiver and ignores the consent requirement can find a deal stalled or blocked even after ROFR has lapsed.

ROFR (Right of First Refusal)
Company or designated parties have the right to purchase shares at the same price and terms offered to the outside buyer. If they decline, the transfer can proceed to the third party.
ROFO (Right of First Offer)
Company has the right to make an offer before the seller approaches outside buyers. Different process, similar intent — limits who the seller can approach first.
Consent right
A separate board or administrator approval requirement. Company can deny the transfer outright without purchasing the shares. Does not require the company to match price or provide a reason.
Lock-up
A time-based restriction that prevents transfers for a specified period, typically after a grant date or event. Distinct from ROFR and consent — it is a pure time bar.

Why companies use discretionary consent

Companies maintain discretionary consent for several legitimate reasons. They want to control who sits on their cap table — an unknown secondary buyer could become a disruptive shareholder, demand information rights, or complicate future financing. They may also want to avoid triggering Section 12(g) of the Exchange Act, which imposes public reporting requirements if a company exceeds 2,000 record holders or 500 non-accredited holders. A company approaching those thresholds has a strong incentive to restrict the expansion of its shareholder list.

Companies also use consent rights to manage the timing of secondary activity relative to their own fundraising plans. A company in the middle of a primary round negotiation may prefer to suppress secondary transactions that could set a lower market price than the round it is trying to close. Blocking secondary sales during sensitive windows is a common, if commercially uncomfortable, use of this power.

A company exercising its consent right is not required to buy your shares. You can be blocked without compensation and without any obligation on the company's part to explain its reasoning.

What to look for in your equity documents before listing

Before approaching any secondary marketplace, sellers should review three specific documents: the stock option plan (or restricted stock purchase agreement), any stockholder agreement you signed at grant or purchase, and the company's certificate of incorporation or LLC agreement. The transfer restriction language is typically in all three, and they interact. Look specifically for the phrase 'consent of the board' or 'approval of the company' as a condition precedent to transfer. If you see that language, assume a two-step process: ROFR waiver and consent grant.

Also check whether the consent right applies only to stock or whether it extends to any economic interest in the stock — including interests in an SPV or forward contract structured around your shares. Some newer agreements specifically prohibit synthetic transfers designed to route around the direct transfer restriction. If your agreement has that language, a structured vehicle may be subject to consent requirements as well.

Practical steps for sellers facing consent requirements

  1. Read your equity plan documents before approaching a buyer. Identify whether a consent requirement exists separate from ROFR.
  2. Reach out to your company's equity or legal team early — before a purchase agreement is signed — to ask whether the company is currently approving secondary transfers. Most companies have an informal posture even if it isn't public.
  3. Ask the marketplace whether it has current experience with consent timelines for your specific issuer. Experienced secondary platforms have visibility into how long these processes take and whether companies are actively approving transfers.
  4. Build consent timing into your expected settlement window. If ROFR takes up to 30 days and consent is a separate process that takes an additional two to four weeks, a 60-day overall timeline is realistic, not exceptional.
  5. Understand what happens if consent is denied. Your purchase agreement should specify whether the deal terminates without penalty, whether a deposit is refunded, and what obligations, if any, the buyer has on fall-through.

How fall-through risk is allocated

When a transfer is blocked by a consent denial, the deal fails. This is called a fall-through. Who bears that risk depends on how the purchase agreement is drafted. In well-structured agreements, the fall-through is a no-fault termination — neither party owes the other damages, and any escrow is returned to the buyer. In poorly drafted agreements, sellers can find themselves liable for costs incurred by a buyer who has already conducted due diligence and arranged funding.

Sellers should review fall-through provisions before signing any purchase agreement, not after. The allocation of consent-denial risk is a negotiating point, and sellers with strong-demand shares have more leverage to negotiate clean termination rights.

Starting your process with the right information

Limen Markets works through the ROFR clearance process in parallel with execution, which reduces timeline drag in most standard ROFR situations. For transactions where a separate consent right exists, we flag this during the initial seller review so both parties understand the approval path before the purchase agreement is executed. This is why reviewing your transfer documents before you list is the single most useful thing a seller can do.

If you hold equity in one of the 28 issuers on our platform and want to understand the transfer process before committing to a listing, visit /sell to start a confidential review. Our team will help you identify what consent conditions apply to your specific agreement and what timeline is realistic given current company posture.